Subscribe free

Metabolic and Bariatric Surgery ·

Underutilization of Anti-obesity Medications Post-Bariatric Surgery

After bariatric surgery, many patients experience insufficient weight loss or regain. This study examines the utilization of anti-obesity medications (AOMs) post-surgery using a large database. Among 59,160 patients, AOM use was highest for topiramate, with varying age and racial distributions. Despite weight concerns, AOMs are underused, suggesting a need to address barriers and consider AOMs earlier for patients with inadequate weight loss post-bariatric surgery.

Journal Article by Firkins SA, Chittajallu V (…) Simons-Linares R et 2 al. in Obes Surg

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Obes Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →